Tapewire

NYSE · USD

HLF

HERBALIFE LTD.

Export transactions ↓
Tapewire entity
4842
SEC CIK
0001180262
Parsed reports
546

Last 12 months

Inside the activity.

4 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202520
Dec 202510
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2024 Filed May 10, 2024 20:43 UTC PurchaseCommon Stock 7,000 $10.65 $74,550.00
Disclosure

SEC source: 0000950170-24-057907 · ownership.xml · nonDerivative · entry 3

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,279

F2 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $10.60 to $10.70. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:43 UTC PurchaseCommon Stock 5,500 $10.59 $58,245.00
Disclosure

SEC source: 0000950170-24-057907 · ownership.xml · nonDerivative · entry 2

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,279

F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $10.48 to $10.70. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:43 UTC PurchaseCommon Stock 2,500 $10.17 $25,425.00
Disclosure

SEC source: 0000950170-24-057907 · ownership.xml · nonDerivative · entry 1

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,779

Read SEC document
May 07, 2024 Filed May 8, 2024 21:59 UTC PurchaseCommon Stock 5,000 $9.73 $48,650.00
Disclosure

SEC source: 0000950170-24-055980 · ownership.xml · nonDerivative · entry 2

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,279

Read SEC document
May 06, 2024 Filed May 8, 2024 21:59 UTC PurchaseCommon Stock 3,000 $9.67 $29,010.00
Disclosure

SEC source: 0000950170-24-055980 · ownership.xml · nonDerivative · entry 1

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,279

Read SEC document
May 04, 2024 Filed May 7, 2024 22:42 UTC
Wang Henry CEVP, General Counsel
Tax withholdingCommon Stock 4,348 $9.58 $41,653.84
Disclosure

SEC source: 0000950170-24-054883 · ownership.xml · nonDerivative · entry 2

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,325

F3 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on May 4, 2023.

Read SEC document
May 04, 2024 Filed May 7, 2024 22:24 UTC
Montesino IbelisEVP & Chief of Staff
Tax withholdingCommon Stock 2,019 $9.58 $19,342.02
Disclosure

SEC source: 0000950170-24-054859 · ownership.xml · nonDerivative · entry 2

Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,812

F3 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on May 4, 2023.

Read SEC document
May 04, 2024 Filed May 7, 2024 22:21 UTC
Lamberti FrankChief Operating Officer
Tax withholdingCommon Stock 2,019 $9.58 $19,342.02
Disclosure

SEC source: 0000950170-24-054855 · ownership.xml · nonDerivative · entry 2

Lamberti Frank · CIK 0001661501 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,838

F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on May 4, 2023.

Read SEC document
May 04, 2024 Filed May 7, 2024 22:12 UTC Tax withholdingCommon Stock 3,726 $9.58 $35,695.08
Disclosure

SEC source: 0000950170-24-054845 · ownership.xml · nonDerivative · entry 2

Irani Jehangir D · CIK 0001775818 · SVP, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,573

F2 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on May 4, 2023.

Read SEC document
May 03, 2024 Filed May 6, 2024 17:52 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053404 · ownership.xml · nonDerivative · entry 2

Mulligan Donal L · CIK 0001406019 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,246

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 6, 2024 17:52 UTC PurchaseCommon Stock 30,000 $9.65 $289,500.00
Disclosure

SEC source: 0000950170-24-053404 · ownership.xml · nonDerivative · entry 1

Mulligan Donal L · CIK 0001406019 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 60,000

Read SEC document
May 03, 2024 Filed May 7, 2024 23:09 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054918 · ownership.xml · nonDerivative · entry 1

L'Helias Sophie · CIK 0001849394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,746

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:42 UTC
Wang Henry CEVP, General Counsel
GrantStock Appreciation Rights · Derivative 212,550 $0.00 Strike: $9.58 $0.00
Disclosure

SEC source: 0000950170-24-054883 · ownership.xml · derivative · entry 3

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,550

Underlying: Common Stock · 212,550 shares

Expires 2034-05-03

F4 · derivative.exercise_date: Consists of stock appreciation right ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:42 UTC
Wang Henry CEVP, General Counsel
GrantCommon Stock 36,534 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054883 · ownership.xml · nonDerivative · entry 1

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,673

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

F2 · balance_after: Balance includes 945 shares purchased through the Issuer's Employee Stock Purchase Plan since the Reporting Person's last Form 4 filing on March 27, 2024.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:39 UTC
Otero MariaDirector
GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054879 · ownership.xml · nonDerivative · entry 1

Otero Maria · CIK 0001594205 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,193

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:37 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054876 · ownership.xml · nonDerivative · entry 1

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,279

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:34 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054873 · ownership.xml · nonDerivative · entry 1

Macadrai Rodica · CIK 0001993942 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,705

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:31 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054870 · ownership.xml · nonDerivative · entry 1

LEVITT MICHAEL J · CIK 0001228160 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,657

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:28 UTC GrantCommon Stock 18,266 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054866 · ownership.xml · nonDerivative · entry 1

LeFevre Alan W · CIK 0001610428 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,117

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:24 UTC
Montesino IbelisEVP & Chief of Staff
GrantStock Appreciation Rights · Derivative 151,821 $0.00 Strike: $9.58 $0.00
Disclosure

SEC source: 0000950170-24-054859 · ownership.xml · derivative · entry 3

Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,821

Underlying: Common Stock · 151,821 shares

Expires 2034-05-03

F4 · derivative.exercise_date: Consists of stock appreciation right ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:24 UTC
Montesino IbelisEVP & Chief of Staff
GrantCommon Stock 26,096 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054859 · ownership.xml · nonDerivative · entry 1

Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,831

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

F2 · balance_after: This amount includes 1,428 shares held by the Reporting Person prior to becoming subject to Section 16 that were not previously included due to an administrative error.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:21 UTC
Lamberti FrankChief Operating Officer
GrantStock Appreciation Rights · Derivative 212,550 $0.00 Strike: $9.58 $0.00
Disclosure

SEC source: 0000950170-24-054855 · ownership.xml · derivative · entry 3

Lamberti Frank · CIK 0001661501 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,550

Underlying: Common Stock · 212,550 shares

Expires 2034-05-03

F3 · derivative.exercise_date: Consists of stock appreciation right ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:21 UTC
Lamberti FrankChief Operating Officer
GrantCommon Stock 36,534 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054855 · ownership.xml · nonDerivative · entry 1

Lamberti Frank · CIK 0001661501 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,857

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:12 UTC GrantCommon Stock 31,315 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054845 · ownership.xml · nonDerivative · entry 1

Irani Jehangir D · CIK 0001775818 · SVP, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,299

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:09 UTC GrantStock Appreciation Rights · Derivative 349,190 $0.00 Strike: $9.58 $0.00
Disclosure

SEC source: 0000950170-24-054836 · ownership.xml · derivative · entry 2

Gratziani Stephan Paulo · CIK 0001976128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,190

Underlying: Common Stock · 349,190 shares

Expires 2034-05-03

F2 · derivative.exercise_date: Consists of stock appreciation right ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:09 UTC GrantCommon Stock 60,020 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054836 · ownership.xml · nonDerivative · entry 1

Gratziani Stephan Paulo · CIK 0001976128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,796

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of May 3, 2025, May 3, 2026, and May 3, 2027, subject to continued service through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:05 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054831 · ownership.xml · nonDerivative · entry 1

Del Genes Celine · CIK 0001926601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,961

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:02 UTC GrantCommon Stock 15,657 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-054825 · ownership.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,909

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 23:31 UTC
Wang Henry CEVP, General Counsel
PurchaseCommon Stock 2,778 $9.30 $25,835.40
Disclosure

SEC source: 0000950170-24-037453 · ownership.xml · nonDerivative · entry 1

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,194

F1 · balance_after: This amount includes 400 additional shares purchased on August 20, 2014 at $25.02 per share that were not previously reported due to an administrative error.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 23:27 UTC PurchaseCommon Stock 16,079 $9.40 $151,142.60
Disclosure

SEC source: 0000950170-24-037450 · ownership.xml · nonDerivative · entry 1

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,622

F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $9.34 to $9.62. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 23:25 UTC PurchaseCommon Stock 5,332 $9.40 $50,120.80
Disclosure

SEC source: 0000950170-24-037448 · ownership.xml · nonDerivative · entry 1

Macadrai Rodica · CIK 0001993942 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,048

Read SEC document
March 26, 2024 Filed Mar 27, 2024 23:22 UTC PurchaseCommon Stock 1,888 $9.42 $17,784.96
Disclosure

SEC source: 0000950170-24-037446 · ownership.xml · nonDerivative · entry 1

Del Genes Celine · CIK 0001926601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,304

Read SEC document
March 25, 2024 Filed Mar 27, 2024 23:19 UTC
DeSimone JohnChief Financial Officer
GrantStock Appreciation Rights · Derivative 1,532,769 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0000950170-24-037443 · ownership.xml · derivative · entry 1

DeSimone John · CIK 0001463405 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,532,769

Underlying: Common Stock · 1,532,769 shares

Expires 2034-03-25

F1 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on March 25, 2025, and 50% on March 25, 2026, subject to certain conditions of his service as Chief Financial Officer.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 20:19 UTC PurchaseCommon Stock 4,421 $9.14 $40,407.94
Disclosure

SEC source: 0000950170-24-029965 · ownership.xml · nonDerivative · entry 2

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,543

F2 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $9.09 to $9.60. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 21:00 UTC PurchaseCommon Stock 5,175 $9.31 $48,179.25
Disclosure

SEC source: 0000950170-24-030884 · ownership.xml · nonDerivative · entry 1

Macadrai Rodica · CIK 0001993942 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,716

F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $9.25 to $9.67. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
March 08, 2024 Filed Mar 12, 2024 20:19 UTC PurchaseCommon Stock 6,500 $9.14 $59,410.00
Disclosure

SEC source: 0000950170-24-029965 · ownership.xml · nonDerivative · entry 1

Mendoza Juan Miguel · CIK 0001738284 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,122

F1 · price: This transaction represents multiple open market purchases. The range of prices for such transactions is $9.12 to $9.15. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price.

Read SEC document
March 03, 2024 Filed Mar 5, 2024 22:26 UTC
Amezquita AlexanderChief Financial Officer
Tax withholdingCommon Stock 116 $8.75 $1,015.00
Disclosure

SEC source: 0000950170-24-026296 · ownership.xml · nonDerivative · entry 1

Amezquita Alexander · CIK 0001721325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,042

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on March 3, 2021.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 22:05 UTC
Wang Henry CEVP, General Counsel
Tax withholdingCommon Stock 616 $8.67 $5,340.72
Disclosure

SEC source: 0000950170-24-021358 · ownership.xml · nonDerivative · entry 1

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,016

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 22:02 UTC
Montesino IbelisEVP & Chief of Staff
Tax withholdingCommon Stock 896 $8.67 $7,768.32
Disclosure

SEC source: 0000950170-24-021345 · ownership.xml · nonDerivative · entry 1

Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,307

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 21:58 UTC
Lamberti FrankChief Operating Officer
Tax withholdingCommon Stock 310 $8.67 $2,687.70
Disclosure

SEC source: 0000950170-24-021323 · ownership.xml · nonDerivative · entry 1

Lamberti Frank · CIK 0001661501 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,323

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 21:55 UTC Tax withholdingCommon Stock 515 $8.67 $4,465.05
Disclosure

SEC source: 0000950170-24-021313 · ownership.xml · nonDerivative · entry 1

Irani Jehangir D · CIK 0001775818 · SVP, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,984

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022.

Read SEC document
February 25, 2024 Filed Feb 27, 2024 21:51 UTC
Amezquita AlexanderChief Financial Officer
Tax withholdingCommon Stock 616 $8.67 $5,340.72
Disclosure

SEC source: 0000950170-24-021301 · ownership.xml · nonDerivative · entry 1

Amezquita Alexander · CIK 0001721325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,158

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 25, 2022.

Read SEC document
February 19, 2024 Filed Feb 21, 2024 23:07 UTC
Wang Henry CEVP, General Counsel
Tax withholdingCommon Stock 1,018 $8.07 $8,215.26
Disclosure

SEC source: 0000950170-24-018223 · ownership.xml · nonDerivative · entry 1

Wang Henry C · CIK 0001738879 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,632

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 19, 2021.

Read SEC document
February 19, 2024 Filed Feb 21, 2024 23:03 UTC Tax withholdingCommon Stock 1,170 $8.07 $9,441.90
Disclosure

SEC source: 0000950170-24-018219 · ownership.xml · nonDerivative · entry 1

Irani Jehangir D · CIK 0001775818 · SVP, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,499

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 19, 2021.

Read SEC document
February 19, 2024 Filed Feb 21, 2024 22:59 UTC
Montesino IbelisEVP & Chief of Staff
Tax withholdingCommon Stock 2,036 $8.07 $16,430.52
Disclosure

SEC source: 0000950170-24-018209 · ownership.xml · nonDerivative · entry 1

Montesino Ibelis · CIK 0001513887 · EVP & Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,203

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 19, 2021.

Read SEC document
February 19, 2024 Filed Feb 21, 2024 22:56 UTC
Amezquita AlexanderChief Financial Officer
Tax withholdingCommon Stock 637 $8.07 $5,140.59
Disclosure

SEC source: 0000950170-24-018205 · ownership.xml · nonDerivative · entry 1

Amezquita Alexander · CIK 0001721325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,774

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 19, 2021.

Read SEC document
February 19, 2024 Filed Feb 21, 2024 22:54 UTC
Lamberti FrankChief Operating Officer
Tax withholdingCommon Stock 827 $8.07 $6,673.89
Disclosure

SEC source: 0000950170-24-018202 · ownership.xml · nonDerivative · entry 1

Lamberti Frank · CIK 0001661501 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,633

F1 · shares: Represents shares withheld to satisfy tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 19, 2021.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 22:49 UTC GrantStock Appreciation Rights · Derivative 165,847 $0.00 Strike: $8.07 $0.00
Disclosure

SEC source: 0000950170-24-018193 · ownership.xml · derivative · entry 2

Gratziani Stephan Paulo · CIK 0001976128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,847

Underlying: Common Stock · 165,847 shares

Expires 2034-02-16

F2 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 16, 2025, February 16, 2026, and February 16, 2027, subject to continued service through such date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 22:49 UTC GrantCommon Stock 27,881 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-018193 · ownership.xml · nonDerivative · entry 1

Gratziani Stephan Paulo · CIK 0001976128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,776

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in one-third increments on each of February 16, 2025, February 16, 2026, and February 16, 2027, subject to continued service through such date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 22:44 UTC
JOHNSON MICHAELDirector · Chairman & CEO
GrantStock Appreciation Rights · Derivative 982,800 $0.00 Strike: $8.07 $0.00
Disclosure

SEC source: 0000950170-24-018170 · ownership.xml · derivative · entry 5

JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 982,800

Underlying: Common Stock · 982,800 shares

Expires 2034-02-16

F5 · derivative.exercise_date: Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.